Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
PBMs negotiate rebates with drugmakers, and these behind-the-scenes deals often determine which medication you can get regardless of what's best for patients
Importantly, no gastrointestinal adverse events were observed during tirzepatide therapy in this cohort
Pause halfway through and check in
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 186,36 per year only 15,53 per issue Buy this article Purchase on SpringerLink Instant access to the full article PDF
